Literature DB >> 16373404

A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system.

Luis Bahamondes1, Ximena Espejo-Arce, Maria M Hidalgo, Creusa Hidalgo-Regina, Cássia Teatin-Juliato, Carlos A Petta.   

Abstract

BACKGROUND: There are concerns about the effect of hormonal contraceptives on bone mineral density (BMD), but there is currently no information available on the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on BMD. The objective of this study was to compare the BMD of LNG-IUS users with that of controls using the TCu380A intrauterine device (IUD).
MATERIALS AND METHODS: A cross-sectional study paired 53 women, aged 25-51 years, who had been using the LNG-IUS for 7 years, with 53 IUD users, according to age (+/-1 year) and body mass index (BMI; kg/m2) (+/-1). BMD was evaluated at the midshaft of the ulna and the distal radius of the nondominant forearm using double X-ray absorptiometry.
RESULTS: Mean age of women was 34 years. BMI was slightly over 25 in both groups. Estradiol was normal. Mean BMD was 0.469 +/- 0.008 and 0.467 +/- 0.009 and 0.409 +/- 0.009 and 0.411 +/- 0.009 at the midshaft of the ulna and distal radius in LNG-IUS and IUD users, respectively, without significant differences.
CONCLUSIONS: Women aged 25-51 years, using the LNG-IUS for 7 years, had a mean BMD similar to that of the control group of TCu380A IUD users.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373404     DOI: 10.1093/humrep/dei457

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Osteoporosis in a young woman after 6 years of levonorgestrel administration from intrauterine devices?

Authors:  Christine Ursula Greiner; Kay Brune; Ekkehard Haen
Journal:  BMJ Case Rep       Date:  2009-03-05

Review 2.  Update on hormonal contraception and bone density.

Authors:  Michelle M Isley; Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

Review 3.  Contraception for cancer survivors.

Authors:  Eleanor Bimla Schwarz; Rachel Hess; James Trussell
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

4.  Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice.

Authors:  Ellen Menkhorst; Jian-Guo Zhang; Natalie A Sims; Phillip O Morgan; Priscilla Soo; Ingrid J Poulton; Donald Metcalf; Estella Alexandrou; Melissa Gresle; Lois A Salamonsen; Helmut Butzkueven; Nicos A Nicola; Evdokia Dimitriadis
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

5.  Role of the levonorgestrel intrauterine system in effective contraception.

Authors:  Abdelhamid M Attia; Magdy M Ibrahim; Ahmed M Abou-Setta
Journal:  Patient Prefer Adherence       Date:  2013-08-09       Impact factor: 2.711

6.  Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.

Authors:  Chandra Kailasam; David Cahill
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

Review 7.  Hormonal Contraception and Bone Health in Adolescents.

Authors:  Laura K Bachrach
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-21       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.